# PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

> **NCT06511037** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 10 (estimated)

## Conditions studied

- Gastrointestinal Cancer
- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging

## Key facts

- **NCT ID:** NCT06511037
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-13
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511037, "PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06511037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*